The global Radiopharmaceuticals market size in 2022 is 5200.0 million US dollars, and it is expected to be XX million US dollars by 2029, with a compound annual growth rate of 9.40% expected in 2023-2029.
MARKET COMPETITIVE LANDSCAPE:
The main players in the Radiopharmaceuticals market include Cardinal Health (U.S.), GE Healthcare (U.S.), Lantheus Medical Imaging (U.S.), Bayer AG (Germany), and Bracco Imaging (Italy). The share of the top 3 players in the Radiopharmaceuticals market is XX%.
REGION SHARE:
The report covers the market size information of North America, Europe, Asia Pacific, Latin America, Middle East and Africa, and North America accounted for XX%, Europe accounted for XX% of Radiopharmaceuticals market, and Asia Pacific accounted for XX%.
SEGMENT OVERVIEW:
The report segments the market by Type and Application. Diagnostic Procedures accounted for XX% of Radiopharmaceuticals market in 2022. Therapeutic Procedures share of XX%.
Nuclear Reactors accounted for XX% of the Radiopharmaceuticals market in 2022. Cyclotrons accounts for XX%.
Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
COVID-19 Impact:
Outbreak of COVID-19 pandemic due to lockdown restrictions imposed by governments around the world has affected the growth of the global Radiopharmaceuticals market in 2020. The containment measures taken by the governments of various countries in response to control the outbreak of COVID-19 disrupted the entire supply chain by creating logistical interruptions, transportation restrictions, and product supply across borders.
The report analyzes the key trends in each segment of the global Radiopharmaceuticals market along with global and country-level forecasts from 2023 to 2028. Our report segments the market based on types and applications, thereby providing a detailed analysis of the market to help gain an in-depth understanding of the market and enable market participants, stakeholders, investors, etc. to have a clearer understanding of the market and judgment.
Key benefits to stakeholders:
The report provides a comprehensive quantitative analysis of various segments, historical and current market trends, market forecasts, and dynamics of the Radiopharmaceuticals market for 2017-2028.
The research report provides the latest information on the market drivers, challenges and opportunities of the global Radiopharmaceuticals market.
The study profiles the leading as well as the fastest growing regional markets. It further enables stakeholders to identify key country-level markets within each region.
Porter's Five Forces Analysis helps stakeholders assess the impact of new entrants, competitors, supplier strength, buyer strength, and threat of substitution. It helps stakeholders analyze the level of competition in the Radiopharmaceuticals industry and its attractiveness.
The competitive landscape enables stakeholders to understand their competitive environment and gain insight into the current position of the key players in the market.
The life sciences industry grows and continues to advance, driving innovation and improving healthcare outcomes for individuals around the world.
Artificial Intelligence (AI) and Machine Learning (ML): AI and ML technologies are increasingly being employed in life sciences research and development. They aid in drug discovery, optimizing clinical trials, analyzing vast amounts of biological data, and identifying patterns that can lead to breakthroughs in understanding diseases and developing new therapies.
Digital Health Technologies: Digital health technologies have seen rapid growth, especially in areas like telemedicine, wearable devices, and mobile health applications. These technologies enable remote patient monitoring, facilitate better healthcare access, and empower individuals to manage their health more effectively.
Wearable Devices and Remote Monitoring: Wearable devices, such as smartwatches and fitness trackers, have become more sophisticated, enabling continuous monitoring of vital signs and health parameters. These devices offer opportunities for early detection of health issues and improved management of chronic conditions.
Key Regions Covered in This Report Are
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Spain
Nordic
Asia Pacific
China
Japan
South Korea
India
Southeast Asia
Australia
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
Egypt
South Africa
UAE
Turkey
Saudi Arabia
Some of the major players operating in the global market include:
Cardinal Health (U.S.)
GE Healthcare (U.S.)
Lantheus Medical Imaging (U.S.)
Bayer AG (Germany)
Bracco Imaging (Italy)
Nordion (Canada)
Advanced Accelerator Applications (France)
NTP Radioisotopes (South Africa)
NorthStar Medical Radioisotopes (U.S.)
Eckert & Ziegler (Germany)
Braun Melsungen AG (Germany)
Smith+Nephew (Germany)
Segment by Type
Diagnostic Procedures
Therapeutic Procedures
Source
Segment by Application
Nuclear Reactors
Cyclotrons
Table of Content
1 Radiopharmaceuticals Market Introduction and Overview
1.1 Radiopharmaceuticals Definition
1.2 Research Purposes
1.3 Report Timeline
1.4 Economic Analysis of Global Regions
1.5 Inflation Analysis
1.6 The Impact of the Russian-Ukrainian War on the Market
1.7 Coronavirus Disease 2020 (COVID-19) Impact on Global
2 Global Radiopharmaceuticals Historical Market Analysis by Type
2.1 Market Size Analysis by Types
2.2 Global Radiopharmaceuticals Revenue and Market Share by Type
2.3 Global Radiopharmaceuticals Sales and Market Share by Type
3 Global Radiopharmaceuticals Historical Market Analysis by Application
3.1 Market Size Analysis by Application
3.2 Global Radiopharmaceuticals Revenue Market Share by Application (2018-2023)
3.3 Global Radiopharmaceuticals Sales Market Share by Application (2018-2023)
4 Global Market Growth Trends Analysis
4.1 Global Radiopharmaceuticals Market Size (2018-2023)
4.2 Radiopharmaceuticals Growth Trends Analysis by Regions
4.2.1 Radiopharmaceuticals Market Size by Regions: 2018 VS 2023 VS 2029
4.2.2 Radiopharmaceuticals Historic Revenue Market Size by Regions (2018-2023)
4.2.3 Radiopharmaceuticals Historic Sales Market Size by Regions (2018-2023)
4.2.4 North America Radiopharmaceuticals Market Size (2018-2023)
4.2.5 Europe Radiopharmaceuticals Market Size (2018-2023)
4.2.6 Asia-Pacific Radiopharmaceuticals Market Size (2018-2023)
4.2.7 Latin America Radiopharmaceuticals Market Size (2018-2023)
4.2.8 Middle East & Africa Radiopharmaceuticals Market Size (2018-2023)
5 North America
5.1 North America Radiopharmaceuticals Revenue by Countries
5.1.1 North America Radiopharmaceuticals Revenue by Countries (2018-2023)
5.1.2 North America Radiopharmaceuticals Sales by Countries (2018-2023)
5.2 North America Radiopharmaceuticals Sales by Types
5.3 North America Radiopharmaceuticals Sales by Applications
5.4 United States
5.5 Canada
6 Asia Pacific
6.1 Asia Pacific Radiopharmaceuticals Revenue by Countries
6.1.1 Asia Pacific Radiopharmaceuticals Revenue by Countries (2018-2023)
6.1.2 Asia Pacific Radiopharmaceuticals Sales by Countries (2018-2023)
6.2 Asia Pacific Radiopharmaceuticals Sales by Types
6.3 Asia Pacific Radiopharmaceuticals Sales by Applications
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Radiopharmaceuticals Revenue by Countries
7.1.1 Europe Radiopharmaceuticals Revenue by Countries (2018-2023)
7.1.2 Europe Radiopharmaceuticals Sales by Countries (2018-2023)
7.2 Europe Radiopharmaceuticals Sales by Types
7.3 Europe Radiopharmaceuticals Sales by Applications
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Nordic
8 Latin America
8.1 Latin America Radiopharmaceuticals Revenue by Countries
8.1.1 Latin America Radiopharmaceuticals Revenue by Countries (2018-2023)
8.1.2 Latin America Radiopharmaceuticals Sales by Countries (2018-2023)
8.2 Latin America Radiopharmaceuticals Sales by Types
8.3 Latin America Radiopharmaceuticals Sales by Applications
8.4 Brazil
8.5 Argentina
8.6 Mexico
9 Middle East & Africa
9.1 Middle East & Africa Radiopharmaceuticals Revenue by Countries
9.1.1 Middle East & Africa Radiopharmaceuticals Revenue by Countries (2018-2023)
9.1.2 Middle East & Africa Radiopharmaceuticals Sales by Countries (2018-2023)
9.2 Middle East & Africa Radiopharmaceuticals Sales by Types
9.3 Middle East & Africa Radiopharmaceuticals Sales by Applications
9.4 Egypt
9.5 South Africa
9.6 UAE
9.7 Turkey
9.8 Saudi Arabia
10 Global Radiopharmaceuticals Market Competition, by Players
10.1 Global Radiopharmaceuticals Revenue and Market Share by Players
10.2 Market Concentration Rate
10.2.1 Top 3 Radiopharmaceuticals Players Market Share in 2022
10.2.2 Top 6 Radiopharmaceuticals Players Market Share in 2022
10.2.3 Market Competition Trend
10.3 Radiopharmaceuticals Players Head Office, Business Provided
10.4 Radiopharmaceuticals Mergers & Acquisitions
10.5 Radiopharmaceuticals New Entrants and Expansion Plans
11 Players Profiles
11.1 Cardinal Health (U.S.)
11.1.1 Cardinal Health (U.S.) Company Profile
11.1.2 Radiopharmaceuticals Product Overview
11.1.3 Cardinal Health (U.S.) Radiopharmaceuticals Market Performance (2018-2023)
11.1.4 Cardinal Health (U.S.) Business Overview
11.1.5 Recent Developments and Plans
11.2 GE Healthcare (U.S.)
11.2.1 GE Healthcare (U.S.) Company Profile
11.2.2 Radiopharmaceuticals Product Overview
11.2.3 GE Healthcare (U.S.) Radiopharmaceuticals Market Performance (2018-2023)
11.2.4 GE Healthcare (U.S.) Business Overview
11.2.5 Recent Developments and Plans
11.3 Lantheus Medical Imaging (U.S.)
11.3.1 Lantheus Medical Imaging (U.S.) Company Profile
11.3.2 Radiopharmaceuticals Product Overview
11.3.3 Lantheus Medical Imaging (U.S.) Radiopharmaceuticals Market Performance (2018-2023)
11.3.4 Lantheus Medical Imaging (U.S.) Business Overview
11.3.5 Recent Developments and Plans
11.4 Bayer AG (Germany)
11.4.1 Bayer AG (Germany) Company Profile
11.4.2 Radiopharmaceuticals Product Overview
11.4.3 Bayer AG (Germany) Radiopharmaceuticals Market Performance (2018-2023)
11.4.4 Bayer AG (Germany) Business Overview
11.4.5 Recent Developments and Plans
11.5 Bracco Imaging (Italy)
11.5.1 Bracco Imaging (Italy) Company Profile
11.5.2 Radiopharmaceuticals Product Overview
11.5.3 Bracco Imaging (Italy) Radiopharmaceuticals Market Performance (2018-2023)
11.5.4 Bracco Imaging (Italy) Business Overview
11.5.5 Recent Developments and Plans
11.6 Nordion (Canada)
11.6.1 Nordion (Canada) Company Profile
11.6.2 Radiopharmaceuticals Product Overview
11.6.3 Nordion (Canada) Radiopharmaceuticals Market Performance (2018-2023)
11.6.4 Nordion (Canada) Business Overview
11.6.5 Recent Developments and Plans
11.7 Advanced Accelerator Applications (France)
11.7.1 Advanced Accelerator Applications (France) Company Profile
11.7.2 Radiopharmaceuticals Product Overview
11.7.3 Advanced Accelerator Applications (France) Radiopharmaceuticals Market Performance (2018-2023)
11.7.4 Advanced Accelerator Applications (France) Business Overview
11.7.5 Recent Developments and Plans
11.8 NTP Radioisotopes (South Africa)
11.8.1 NTP Radioisotopes (South Africa) Company Profile
11.8.2 Radiopharmaceuticals Product Overview
11.8.3 NTP Radioisotopes (South Africa) Radiopharmaceuticals Market Performance (2018-2023)
11.8.4 NTP Radioisotopes (South Africa) Business Overview
11.8.5 Recent Developments and Plans
11.9 NorthStar Medical Radioisotopes (U.S.)
11.9.1 NorthStar Medical Radioisotopes (U.S.) Company Profile
11.9.2 Radiopharmaceuticals Product Overview
11.9.3 NorthStar Medical Radioisotopes (U.S.) Radiopharmaceuticals Market Performance (2018-2023)
11.9.4 NorthStar Medical Radioisotopes (U.S.) Business Overview
11.9.5 Recent Developments and Plans
11.10 Eckert & Ziegler (Germany)
11.10.1 Eckert & Ziegler (Germany) Company Profile
11.10.2 Radiopharmaceuticals Product Overview
11.10.3 Eckert & Ziegler (Germany) Radiopharmaceuticals Market Performance (2018-2023)
11.10.4 Eckert & Ziegler (Germany) Business Overview
11.10.5 Recent Developments and Plans
11.11 Braun Melsungen AG (Germany)
11.11.1 Braun Melsungen AG (Germany) Company Profile
11.11.2 Radiopharmaceuticals Product Overview
11.11.3 Braun Melsungen AG (Germany) Radiopharmaceuticals Market Performance (2018-2023)
11.11.4 Braun Melsungen AG (Germany) Business Overview
11.11.5 Recent Developments and Plans
11.12 Smith+Nephew (Germany)
11.12.1 Smith+Nephew (Germany) Company Profile
11.12.2 Radiopharmaceuticals Product Overview
11.12.3 Smith+Nephew (Germany) Radiopharmaceuticals Market Performance (2018-2023)
11.12.4 Smith+Nephew (Germany) Business Overview
11.12.5 Recent Developments and Plans
12 Global Radiopharmaceuticals Forecast Market Analysis by Type
12.1 Global Radiopharmaceuticals Revenue Market Forecast by Type (2023-2029)
12.2 Global Radiopharmaceuticals Sales Market Forecast by Type (2023-2029)
13 Global Radiopharmaceuticals Forecast Market Analysis by Application
13.1 Radiopharmaceuticals Revenue Market Forecast by Application (2023-2029)
13.2 Radiopharmaceuticals Sales Market Forecast by Application (2023-2029)
14 Global Market Growth Forecast Analysis
14.1 Global Radiopharmaceuticals Forecast Market Size (2023-2029)
14.2 Radiopharmaceuticals Growth Trends Forecast Analysis by Regions
14.2.1 Radiopharmaceuticals Revenue Forecast Market Size by Regions (2023-2029)
14.2.2 Radiopharmaceuticals Sales Forecast Market Size by Regions (2023-2029)
14.2.3 North America Radiopharmaceuticals Forecast Market Size (2023-2029)
14.2.4 Europe Radiopharmaceuticals Forecast Market Size (2023-2029)
14.2.5 Asia-Pacific Radiopharmaceuticals Forecast Market Size (2023-2029)
14.2.6 Latin America Radiopharmaceuticals Forecast Market Size (2023-2029)
14.2.7 Middle East & Africa Radiopharmaceuticals Forecast Market Size (2023-2029)
15 Radiopharmaceuticals Manufacturing Cost Analysis
15.1 Radiopharmaceuticals Key Raw Materials Analysis
15.1.1 Key Raw Materials
15.1.2 Price Trend of Key Raw Materials
15.1.3 Key Suppliers of Raw Materials
15.2 Proportion of Manufacturing Cost Structure
15.2.1 Raw Materials
15.2.2 Labor Cost
15.2.3 Manufacturing Expenses
15.3 Manufacturing Process Analysis of Radiopharmaceuticals
15.4 Radiopharmaceuticals Industrial Chain Analysis
16 Market Channel, Distributors, Traders and Dealers
16.1 Market Channel Status
16.1.1 Direct Marketing
16.1.2 Indirect Marketing
16.2 Radiopharmaceuticals Typical Distributors
16.3 Radiopharmaceuticals Typical Customers
17 Radiopharmaceuticals Industry Dynamic Analysis
17.1 Radiopharmaceuticals Market Trends Analysis
17.2 Radiopharmaceuticals Market Drivers Analysis
17.3 Radiopharmaceuticals Market Challenges Analysis
17.4 Radiopharmaceuticals Market Restraints Analysis
18 Research Findings and Conclusion
List of Tables and Figures
Figure Radiopharmaceuticals Picture
Table Product Definition of Radiopharmaceuticals
Table Economic Analysis of Global Regions
Table Inflation Analysis
Table The Impact of the Russian-Ukrainian War on the Market
Figure 2020 (COVID-19) Impact on Global Economic Growth 2019, 2020, 2021
Figure Population infected by the Covid-19 of Major Countries
Table Global Radiopharmaceuticals Market Size by Type (2018 VS 2023 VS 2029)
Table Global Radiopharmaceuticals Revenue and Market Size by Type (2018-2023)
Table Global Radiopharmaceuticals Revenue and Market Share by Type (2018-2023)
Table Global Radiopharmaceuticals Sales and Market Size by Type (2018-2023)
Table Global Radiopharmaceuticals Sales and Market Share by Type (2018-2023)
Table Global Radiopharmaceuticals Market Size by Application (2018 VS 2023 VS 2029)
Table Global Radiopharmaceuticals Revenue Market Size by Application (2018-2023)
Table Global Radiopharmaceuticals Revenue Market Share by Application (2018-2023)
Table Global Radiopharmaceuticals Sales Market Size by Application (2018-2023)
Table Global Radiopharmaceuticals Sales Market Share by Application (2018-2023)
Figure Global Radiopharmaceuticals Revenue Market Size (2018-2023)
Figure Global Radiopharmaceuticals Sales Market Size (2018-2023)
Table Radiopharmaceuticals Market Size by Regions: 2018 VS 2023 VS 2029
Table Radiopharmaceuticals Historic Revenue Market Size by Regions (2018-2023)
Table Radiopharmaceuticals Historic Revenue Market Share by Regions (2018-2023)
Table Radiopharmaceuticals Historic Sales Market Size by Regions (2018-2023)
Table Radiopharmaceuticals Historic Sales Market Share by Regions (2018-2023)
Figure North America Radiopharmaceuticals Market Size (2018-2023)
Figure Europe Radiopharmaceuticals Market Size (2018-2023)
Figure Asia-Pacific Radiopharmaceuticals Market Size (2018-2023)
Figure Latin America Radiopharmaceuticals Market Size (2018-2023)
Figure Middle East & Africa Radiopharmaceuticals Market Size (2018-2023)
Table North America Radiopharmaceuticals Revenue by Countries (2018-2023)
Table North America Radiopharmaceuticals Revenue Market Share by Countries (2018-2023)
Table North America Radiopharmaceuticals Sales by Countries (2018-2023)
Table North America Radiopharmaceuticals Sales Market Share by Countries (2018-2023)
Table North America Radiopharmaceuticals Sales by Types (2018-2023)
Table North America Radiopharmaceuticals Sales Market Share by Types (2018-2023)
Table North America Radiopharmaceuticals Sales by Applications (2018-2023)
Table North America Radiopharmaceuticals Sales Market Share by Applications (2018-2023)
Figure United States Radiopharmaceuticals Revenue and Growth (2018-2023)
Figure United States Radiopharmaceuticals Sales and Growth (2018-2023)
Figure Canada Radiopharmaceuticals Revenue and Growth (2018-2023)
Figure Canada Radiopharmaceuticals Sales and Growth (2018-2023)
Table Asia-Pacific Radiopharmaceuticals Revenue by Countries (2018-2023)
Table Asia-Pacific Radiopharmaceuticals Revenue Market Share by Countries (2018-2023)
Table Asia-Pacific Radiopharmaceuticals Sales by Countries (2018-2023)
Table Asia-Pacific Radiopharmaceuticals Revenue Market Share by Countries (2018-2023)
Table Asia Pacific Radiopharmaceuticals Sales by Types (2018-2023)
Table Asia Pacific Radiopharmaceuticals Sales Market Share by Types (2018-2023)
Table Asia Pacific Radiopharmaceuticals Sales by Applications (2018-2023)
Table Asia Pacific Radiopharmaceuticals Sales Market Share by Applications (2018-2023)
Figure China Radiopharmaceuticals Revenue and Growth (2018-2023)
Figure China Radiopharmaceuticals Sales and Growth (2018-2023)
Figure Japan Radiopharmaceuticals Revenue and Growth (2018-2023)
Figure Japan Radiopharmaceuticals Sales and Growth (2018-2023)
Figure Korea Radiopharmaceuticals Revenue and Growth (2018-2023)
Figure Korea Radiopharmaceuticals Sales and Growth (2018-2023)
Figure Southeast Asia Radiopharmaceuticals Revenue and Growth (2018-2023)
Figure Southeast Asia Radiopharmaceuticals Sales and Growth (2018-2023)
Figure India Radiopharmaceuticals Revenue and Growth (2018-2023)
Figure India Radiopharmaceuticals Sales and Growth (2018-2023)
Figure Australia Radiopharmaceuticals Revenue and Growth (2018-2023)
Figure Australia Radiopharmaceuticals Sales and Growth (2018-2023)
Table Europe Radiopharmaceuticals Revenue by Countries (2018-2023)
Table Europe Radiopharmaceuticals Revenue Market Share by Countries (2018-2023)
Table Europe Radiopharmaceuticals Sales by Countries (2018-2023)
Table Europe Radiopharmaceuticals Sales Market Share by Countries (2018-2023)
Table Europe Radiopharmaceuticals Sales by Types (2018-2023)
Table Europe Radiopharmaceuticals Sales Market Share by Types (2018-2023)
Table Europe Radiopharmaceuticals Sales by Applications (2018-2023)
Table Europe Radiopharmaceuticals Sales Market Share by Applications (2018-2023)
Figure Germany Radiopharmaceuticals Revenue and Growth (2018-2023)
Figure Germany Radiopharmaceuticals Sales and Growth (2018-2023)
Figure France Radiopharmaceuticals Revenue and Growth (2018-2023)
Figure France Radiopharmaceuticals Sales and Growth (2018-2023)
Figure UK Radiopharmaceuticals Revenue and Growth (2018-2023)
Figure UK Radiopharmaceuticals Sales and Growth (2018-2023)
Figure Italy Radiopharmaceuticals Revenue and Growth (2018-2023)
Figure Italy Radiopharmaceuticals Sales and Growth (2018-2023)
Figure Russia Radiopharmaceuticals Revenue and Growth (2018-2023)
Figure Russia Radiopharmaceuticals Sales and Growth (2018-2023)
Figure Spain Radiopharmaceuticals Revenue and Growth (2018-2023)
Figure Spain Radiopharmaceuticals Sales and Growth (2018-2023)
Figure Nordic Radiopharmaceuticals Revenue and Growth (2018-2023)
Figure Nordic Radiopharmaceuticals Sales and Growth (2018-2023)
Table Latin America Radiopharmaceuticals Revenue by Countries (2018-2023)
Table Latin America Radiopharmaceuticals Revenue Market Share by Countries (2018-2023)
Table Latin America Radiopharmaceuticals Sales by Countries (2018-2023)
Table Latin America Radiopharmaceuticals Sales Market Share by Countries (2018-2023)
Table Latin America Radiopharmaceuticals Sales by Types (2018-2023)
Table Latin America Radiopharmaceuticals Sales Market Share by Types (2018-2023)
Table Latin America Radiopharmaceuticals Sales by Applications (2018-2023)
Table Latin America Radiopharmaceuticals Sales Market Share by Applications (2018-2023)
Figure Brazil Radiopharmaceuticals Revenue and Growth (2018-2023)
Figure Brazil Radiopharmaceuticals Sales and Growth (2018-2023)
Figure Argentina Radiopharmaceuticals Revenue and Growth (2018-2023)
Figure Argentina Radiopharmaceuticals Sales and Growth (2018-2023)
Figure Mexico Radiopharmaceuticals Revenue and Growth (2018-2023)
Figure Mexico Radiopharmaceuticals Sales and Growth (2018-2023)
Table Middle East & Africa Radiopharmaceuticals Revenue by Countries (2018-2023)
Table Middle East & Africa Radiopharmaceuticals Revenue Market Share by Countries (2018-2023)
Table Middle East & Africa Radiopharmaceuticals Sales by Countries (2018-2023)
Table Middle East & Africa Radiopharmaceuticals Sales Market Share by Countries (2018-2023)
Table Middle East & Africa Radiopharmaceuticals Sales by Types (2018-2023)
Table Middle East & Africa Radiopharmaceuticals Sales Market Share by Types (2018-2023)
Table Middle East & Africa Radiopharmaceuticals Sales by Applications (2018-2023)
Table Middle East & Africa Radiopharmaceuticals Sales Market Share by Applications (2018-2023)
Figure Egypt Radiopharmaceuticals Revenue and Growth (2018-2023)
Figure Egypt Radiopharmaceuticals Sales and Growth (2018-2023)
Figure South Africa Radiopharmaceuticals Revenue and Growth (2018-2023)
Figure South Africa Radiopharmaceuticals Sales and Growth (2018-2023)
Figure UAE Radiopharmaceuticals Revenue and Growth (2018-2023)
Figure UAE Radiopharmaceuticals Sales and Growth (2018-2023)
Figure Turkey Radiopharmaceuticals Revenue and Growth (2018-2023)
Figure Turkey Radiopharmaceuticals Sales and Growth (2018-2023)
Figure Saudi Arabia Radiopharmaceuticals Revenue and Growth (2018-2023)
Figure Saudi Arabia Radiopharmaceuticals Sales and Growth (2018-2023)
Table Global Radiopharmaceuticals Revenue by Players (2018-2023)
Table Global Radiopharmaceuticals Revenue Market Share by Players (2018-2023)
Figure Global Top 3 Companies Revenue Share in 2022
Figure Global Top 6 Companies Revenue Share in 2022
Table Global Radiopharmaceuticals Players Market Concentration Ratio (CR5) (2018-2023)
Table Radiopharmaceuticals Players Head Office, Business Provided
Table Mergers & Acquisitions
Table New Entrants and Expansion Plans
Table Cardinal Health (U.S.) Profile
Table Product Overview
Table Cardinal Health (U.S.) Radiopharmaceuticals Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
Figure Cardinal Health (U.S.) Sales and Growth Rate
Figure Cardinal Health (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table GE Healthcare (U.S.) Profile
Table Product Overview
Table GE Healthcare (U.S.) Radiopharmaceuticals Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
Figure GE Healthcare (U.S.) Sales and Growth Rate
Figure GE Healthcare (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Lantheus Medical Imaging (U.S.) Profile
Table Product Overview
Table Lantheus Medical Imaging (U.S.) Radiopharmaceuticals Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
Figure Lantheus Medical Imaging (U.S.) Sales and Growth Rate
Figure Lantheus Medical Imaging (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Bayer AG (Germany) Profile
Table Product Overview
Table Bayer AG (Germany) Radiopharmaceuticals Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
Figure Bayer AG (Germany) Sales and Growth Rate
Figure Bayer AG (Germany) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Bracco Imaging (Italy) Profile
Table Product Overview
Table Bracco Imaging (Italy) Radiopharmaceuticals Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
Figure Bracco Imaging (Italy) Sales and Growth Rate
Figure Bracco Imaging (Italy) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Nordion (Canada) Profile
Table Product Overview
Table Nordion (Canada) Radiopharmaceuticals Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
Figure Nordion (Canada) Sales and Growth Rate
Figure Nordion (Canada) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Advanced Accelerator Applications (France) Profile
Table Product Overview
Table Advanced Accelerator Applications (France) Radiopharmaceuticals Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
Figure Advanced Accelerator Applications (France) Sales and Growth Rate
Figure Advanced Accelerator Applications (France) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table NTP Radioisotopes (South Africa) Profile
Table Product Overview
Table NTP Radioisotopes (South Africa) Radiopharmaceuticals Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
Figure NTP Radioisotopes (South Africa) Sales and Growth Rate
Figure NTP Radioisotopes (South Africa) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table NorthStar Medical Radioisotopes (U.S.) Profile
Table Product Overview
Table NorthStar Medical Radioisotopes (U.S.) Radiopharmaceuticals Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
Figure NorthStar Medical Radioisotopes (U.S.) Sales and Growth Rate
Figure NorthStar Medical Radioisotopes (U.S.) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Eckert & Ziegler (Germany) Profile
Table Product Overview
Table Eckert & Ziegler (Germany) Radiopharmaceuticals Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
Figure Eckert & Ziegler (Germany) Sales and Growth Rate
Figure Eckert & Ziegler (Germany) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Braun Melsungen AG (Germany) Profile
Table Product Overview
Table Braun Melsungen AG (Germany) Radiopharmaceuticals Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
Figure Braun Melsungen AG (Germany) Sales and Growth Rate
Figure Braun Melsungen AG (Germany) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Smith+Nephew (Germany) Profile
Table Product Overview
Table Smith+Nephew (Germany) Radiopharmaceuticals Sales, Price, Revenue, Gross and Gross Margin (2018-2023)
Figure Smith+Nephew (Germany) Sales and Growth Rate
Figure Smith+Nephew (Germany) Revenue Market Share 2017-2022
Table Business Overview
Table Recent Developments and Plans
Table Global Radiopharmaceuticals Revenue Market Size Forecast by Type (2023-2029)
Table Global Radiopharmaceuticals Revenue Market Share Forecast by Type (2023-2029)
Table Global Radiopharmaceuticals Sales Market Size Forecast by Type (2023-2029)
Table Global Radiopharmaceuticals Sales Market Share Forecast by Type (2023-2029)
Table Global Radiopharmaceuticals Revenue Market Size by Application (2023-2029)
Table Global Radiopharmaceuticals Revenue Market Share by Application (2023-2029)
Table Global Radiopharmaceuticals Sales Market Size by Application (2023-2029)
Table Global Radiopharmaceuticals Sales Market Share by Application (2023-2029)
Figure Global Radiopharmaceuticals Revenue Forecast Market Size (2023-2029)
Figure Global Radiopharmaceuticals Sales Forecast Market Size (2023-2029)
Table Radiopharmaceuticals Revenue Forecast Market Size by Regions (2023-2029)
Table Radiopharmaceuticals Revenue Forecast Market Share by Regions (2023-2029)
Table Radiopharmaceuticals Sales Forecast Market Size by Regions (2023-2029)
Table Radiopharmaceuticals Sales Forecast Market Share by Regions (2023-2029)
Figure North America Radiopharmaceuticals Revenue Forecast Market Size (2023-2029)
Figure North America Radiopharmaceuticals Sales Forecast Market Size (2023-2029)
Figure Europe Radiopharmaceuticals Revenue Forecast Market Size (2023-2029)
Figure Europe Radiopharmaceuticals Sales Forecast Market Size (2023-2029)
Figure Asia-Pacific Radiopharmaceuticals Revenue Forecast Market Size (2023-2029)
Figure Asia-Pacific Radiopharmaceuticals Sales Forecast Market Size (2023-2029)
Figure Latin America Radiopharmaceuticals Revenue Forecast Market Size (2023-2029)
Figure Latin America Radiopharmaceuticals Sales Forecast Market Size (2023-2029)
Figure Middle East & Africa Radiopharmaceuticals Forecast Market Size (2023-2029)
Figure Middle East & Africa Radiopharmaceuticals Sales Forecast Market Size (2023-2029)
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Table Raw Materials Analysis
Table Labor Cost Analysis
Table Manufacturing Expenses Analysis
Figure Manufacturing Process Analysis of Radiopharmaceuticals
Figure Radiopharmaceuticals Industrial Chain Analysis
Table Distributors of Radiopharmaceuticals with Contact Information
Table Major Customers of Radiopharmaceuticals with Contact Information
Table Market Trends Analysis
Table Market Drivers Analysis
Table Market Challenges Analysis
Table Market Restraints Analysis
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
Historical Data (2015-2019) |
|
|
Influencing Factors |
|
|
Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
Market Size |
|
|
Market Position of Top Company |
|
|
Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
Primary Sources | Parameters | Key Data |
Market Segments(by Application, by Type) |
|
|
Total Market |
|
|